T1	Participants 632 695	Center for Tobacco Research and Intervention, Madison, WI, USA.
T2	Participants 720 791;792 882	403 adult, daily smokers without contraindications to bupropion SR use. INTERVENTION Participants were assigned randomly to receive a 9-week course of bupropion S
